Document Detail

The 12-month prevalence and nature of adverse experiences resulting in emergency medical presentations associated with the use of synthetic cannabinoid products.
MedLine Citation:
PMID:  23881887     Owner:  NLM     Status:  In-Data-Review    
OBJECTIVE: A wide range of synthetic cannabinoid products have recently become available through the Internet and shop fronts across the globe. Concerns about the consequences of their use have been prompted by increasing reports of emergency department presentations.
METHODS: An anonymous global online survey was conducted using a research tool based on previous work carried out by the group. Data collection took place during a 4-week period at the end of 2011.
RESULTS: Among 950 last-year users, 23 (2.4%) reported having sought emergency medical treatment following the use of a synthetic cannabinoid product. The most common presentations were panic and anxiety, followed by paranoia and breathing difficulties. Recent users who reported seeking emergency medical treatment were significantly younger (median age 20 years, interquartile range 18-22) than those who did not report seeking treatment (median age 23 years, interquartile range 19-28; Mann-Whitney test, z = 2.89, p = 0.004).
CONCLUSIONS: Synthetic cannabinoid use appears to be associated with a high prevalence of adverse experiences among users, especially younger users. Further research is required to determine whether particular compounds carry a higher risk of harm than others and to assess potential consequences of longer term use. Copyright © 2013 John Wiley & Sons, Ltd.
Adam R Winstock; Monica J Barratt
Related Documents :
23882167 - Learning to walk before we run: what can medical education learn from the human body ab...
22254817 - Mediframe--remote volume rendering visualization framework.
24490317 - The perception of inter-professional education (ipe) among laypersons in a japanese rur...
23731937 - How to perform a systematic search.
11015817 - Cost-effectiveness of clozapine compared with conventional antipsychotic medication for...
11958577 - Cyclophosphamide type i hypersensitivity in systemic lupus erythematosus.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Human psychopharmacology     Volume:  28     ISSN:  1099-1077     ISO Abbreviation:  Hum Psychopharmacol     Publication Date:  2013 Jul 
Date Detail:
Created Date:  2013-07-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8702539     Medline TA:  Hum Psychopharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  390-3     Citation Subset:  IM    
Copyright Information:
Copyright © 2013 John Wiley & Sons, Ltd.
King's College London, London, UK; Global Drug Survey, London, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  "Spiceophrenia": a systematic overview of "Spice"-related psychopathological issues and a case repor...
Next Document:  Classical and novel psychoactive substances: rethinking drug misuse from an evolutionary psychiatric...